Diverse regulation of AKT and GSK-3β by O-GlcNAcylation in various types of cells

FEBS Letters

Volumn 586, Issue 16, 2012, Pages 2443-2450

  Shi, Jianhua ^a,b,c   Wu, Shiliang ^a   Dai, Chun Ling ^c   Li, Yi ^c   Grundke Iqbal, Inge ^c   Iqbal, Khalid ^c   Liu, Fei ^b,c   Gong, Cheng Xin ^b,c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

AKT; Cell types; GSK 3 ; O GlcNAcylation; Phosphorylation

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B;

ACYLATION; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME GLYCOSYLATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; KIDNEY CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLGLUCOSAMINE; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HEP G2 CELLS; HIPPOCAMPUS; HUMANS; INSULIN; MICE; NEURONS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; TISSUE DISTRIBUTION;

EID: 84864287178     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.05.063     Document Type: Article

References (30)

1. G.W. Hart Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins Annu. Rev. Biochem. 66 1997 315 335 (Pubitemid 27274659)
2. Q. Zeidan, and G.W. Hart The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways J. Cell Sci. 123 2010 13 22
3. G.W. Hart, M.P. Housley, and C. Slawson Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins Nature 446 2007 1017 1022 (Pubitemid 46676063)
4. T. Lefebvre Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease Biochim. Biophys. Acta 1800 2010 67 79
5. X. Yang Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance Nature 451 2008 964 969 (Pubitemid 351301737)
6. R. Dentin, S. Hedrick, J. Xie, J. Yates 3rd, and M. Montminy Hepatic glucose sensing via the CREB coactivator CRTC2 Science 319 2008 1402 1405 (Pubitemid 351354877)
7. D.A. McClain, W.A. Lubas, R.C. Cooksey, M. Hazel, G.J. Parker, D.C. Love, and J.A. Hanover Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia Proc. Natl. Acad. Sci. U S A 99 2002 10695 10699
8. K.A. Robinson, L.E. Ball, and M.G. Buse Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 292 2007 E884 E890
9. M.S. Macauley, Y. He, T.M. Gloster, K.A. Stubbs, G.J. Davies, and D.J. Vocadlo Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes Chem. Biol. 17 2010 937 948
10. M.S. Macauley, X. Shan, S.A. Yuzwa, T.M. Gloster, and D.J. Vocadlo Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis Chem. Biol. 17 2010 949 958
11. A. Bensadoun, and D. Weinstein Assay of proteins in the presence of interfering materials Anal. Biochem. 70 1976 241 250
12. A. Brunet Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Exp. Cell Res. 96 1999 857 868 (Pubitemid 29165088)
13. C. Yost, M. Torres, J.R. Miller, E. Huang, D. Kimelman, and R.T. Moon The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3 Genes Dev. 10 1996 1443 1454 (Pubitemid 26260702)
14. S.Y. Park, J. Ryu, and W. Lee O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes Exp. Mol. Med. 37 2005 220 229 (Pubitemid 40992738)
15. Z. Wang, A. Pandey, and G.W. Hart Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation Mol. Cell Proteomics 6 2007 1365 1379 (Pubitemid 47365435)
16. K. Vosseller, L. Wells, M.D. Lane, and G.W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes Proc. Natl. Acad. Sci. U S A 99 2002 5313 5318 (Pubitemid 34411545)
17. Y.A. Soesanto, B. Luo, D. Jones, R. Taylor, J.S. Gabrielsen, G. Parker, and D.A. McClain Regulation of Akt signaling by O-GlcNAc in euglycemia Am. J. Physiol. Endocrinol. Metab. 295 2008 E974 E980
18. K. Gerozissis Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies Eur. J. Pharmacol. 585 2008 38 49
19. Y. Liu, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes Am. J. Pathol. 225 2011 54 62
20. Y. Deng, B. Li, Y. Liu, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease Am. J. Pathol. 175 2009 2089 2098
21. Z. Kroner The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern. Med. Rev. 14 2009 373 379
22. H. Pilcher Alzheimer's disease could be "type 3 diabetes" Lancet Neurol. 5 2006 388 389
23. Y. Liu, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease J. Neurochem. 111 2009 242 249
24. C.X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation J. Alzheimers Dis. 9 2006 1 12
25. F. Liu, K. Iqbal, I. Grundke-Iqbal, G.W. Hart, and C.X. Gong O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease Proc. Natl. Acad. Sci. U S A 101 2004 10804 10809 (Pubitemid 38955823)
26. F. Liu, J. Shi, H. Tanimukai, J. Gu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease Brain 132 2009 1820 1832
27. B. Luo, Y. Soesanto, and D.A. McClain Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells Arterioscler. Thromb. Vasc. Biol. 28 2008 651 657 (Pubitemid 351651338)
28. E.S. Kang O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells Exp. Cell Res. 314 2008 2238 2248
29. H. Goldberg, C. Whiteside, and I.G. Fantus O-linked {beta}-N- acetylglucosamine (O-GlcNAc) supports p38 MAPK activation by high glucose in glomerular mesangial cells Am J Physiol. Endocrinol. Metab. 301 2011 E713 E726
30. J.C. Gandy, A.E. Rountree, and G.N. Bijur Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1 FEBS Lett. 580 2006 3051 3058 (Pubitemid 43729656)